Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.

Procedural entryThis page is a short order in Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.. Read the opinion of the Court — 786 F.3d 892
Court of Appeals for the Federal Circuit·Decided October 17, 2017·No. 17-1033·Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

CLASSEN IMMUNOTHERAPIES, INC., A MARYLAND CORPORATION, Plaintiff-Appellant

JOHN BARTHELOW CLASSEN, Counterclaim Defendant

v.

ELAN PHARMACEUTICALS, INC., A DELAWARE CORPORATION, Defendant/Counterclaimant-Appellee ______________________

2017-1033 ______________________

Appeal from the United States District Court for the District of Maryland in No. 1:04-cv-03521-RDB, Judge Richard D. Bennett. ______________________

JUDGMENT ______________________

JOSEPH J. ZITO, DNL ZITO, Washington, DC, argued for plaintiff-appellant. Also represented by LUIZ FELIPE V S C DE OLIVEIRA. JAMES B. MONROE, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC, argued for defendant/counterclaimant-appellee. Also represented by PAUL WILLIAM BROWNING. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (PROST, Chief Judge, LOURIE and TARANTO, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

October 17, 2017 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Free access — add to your briefcase to read the full text and ask questions with AI

Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc., (Fed. Cir. 2017).

Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc. (Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.